{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:26:02Z","timestamp":1793229962251,"version":"4.5.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","gynecologiconcology-online.net","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ygyno.2025.02.008","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T13:54:41Z","timestamp":1740059681000},"page":"86-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Predicting lymph node metastases in three different vulvar squamous cell carcinoma subgroups"],"prefix":"10.1016","volume":"194","author":[{"given":"Anne F.","family":"van Velzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Tulling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte I.E.","family":"van Poelgeest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjalling","family":"Bosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena C.","family":"van Doorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim E.","family":"Kortekaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Nooij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2025.02.008_bb0005","series-title":"Vulva Cancer. StatPearls. Treasure Island (FL)","author":"Capria","year":"2022"},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.008_bb0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijgo.13880","article-title":"FIGO staging for carcinoma of the vulva: 2021 revision","volume":"155","author":"Olawaiye","year":"2021","journal-title":"Int. J. Gynecol. Obstet."},{"issue":"4","key":"10.1016\/j.ygyno.2025.02.008_bb0020","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ijgc-00009577-200307000-00019","article-title":"Postoperative complications after vulvectomy and inguinofemoral lymphadenectomy using separate groin incisions","volume":"13","author":"Gaarenstroom","year":"2003","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"6","key":"10.1016\/j.ygyno.2025.02.008_bb0025","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2007.14.0566","article-title":"Sentinel node dissection is safe in the treatment of early-stage vulvar cancer","volume":"26","author":"Van der Zee","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ygyno.2025.02.008_bb0030","doi-asserted-by":"crossref","unstructured":"M.H.M. Oonk, F. Planchamp, P. Baldwin, S. Mahner, M.R. Mirza, D. Fischerov\u00e1, et al., European society of gynaecological oncology guidelines for the management of patients with vulvar cancer - update 2023, Int. J. Gynecol. Cancer (2023) ijgc-2023-004486. Volume 33, Issue 7, Pages 1023-1043","DOI":"10.1136\/ijgc-2023-004486"},{"issue":"11","key":"10.1016\/j.ygyno.2025.02.008_bb0035","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/cncr.10969","article-title":"Vulvar carcinoma","volume":"95","author":"de Hullu","year":"2002","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.008_bb0040","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ygyno.2020.09.024","article-title":"Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes","volume":"159","author":"Kortekaas","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.ygyno.2025.02.008_bb0045","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3739075","article-title":"The clinical relevance of p16 and p53 status in patients with squamous cell carcinoma of the vulva","volume":"2020","author":"Barlow","year":"2020","journal-title":"J. Oncol."},{"issue":"3","key":"10.1016\/j.ygyno.2025.02.008_bb0050","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/LGT.0000000000000182","article-title":"Biomarkers p16, human papillomavirus and p53 predict recurrence and survival in early stage squamous cell carcinoma of the vulva","volume":"20","author":"Hay","year":"2016","journal-title":"J. Low. Genit. Tract Dis."},{"issue":"2","key":"10.1016\/j.ygyno.2025.02.008_bb0055","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/his.13205","article-title":"Human papillomavirus (HPV)-independent vulvar squamous cell carcinoma has a worse prognosis than HPV-associated disease: a retrospective cohort study","volume":"71","author":"McAlpine","year":"2017","journal-title":"Histopathology"},{"issue":"22","key":"10.1016\/j.ygyno.2025.02.008_bb0060","doi-asserted-by":"crossref","first-page":"6781","DOI":"10.1158\/1078-0432.CCR-17-1302","article-title":"Genomic characterization of vulvar (pre)cancers identifies distinct molecular subtypes with prognostic significance","volume":"23","author":"Nooij","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.008_bb0065","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ygyno.2018.10.015","article-title":"The prognostic value of p16 and p53 expression for survival after vulvar cancer: a systematic review and meta-analysis","volume":"152","author":"Sand","year":"2019","journal-title":"Gynecol. Oncol."},{"issue":"6","key":"10.1016\/j.ygyno.2025.02.008_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2020.12.1220","article-title":"p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gyn\u00e4kologische Onkologie chemo and radiotherapy in epithelial vulvar Cancer study group","volume":"224","author":"Woelber","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"8","key":"10.1016\/j.ygyno.2025.02.008_bb0075","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1038\/s41379-020-0524-1","article-title":"Major p53 immunohistochemical patterns in in situ and invasive squamous cell carcinomas of the vulva and correlation with TP53 mutation status","volume":"33","author":"Tessier-Cloutier","year":"2020","journal-title":"Mod. Pathol."},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.008_bb0080","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"issue":"1","key":"10.1016\/j.ygyno.2025.02.008_bb0085","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/his.14109","article-title":"Performance of the pattern-based interpretation of p53 immunohistochemistry as a surrogate for TP53 mutations in vulvar squamous cell carcinoma","volume":"77","author":"Kortekaas","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.ygyno.2025.02.008_bb0090","doi-asserted-by":"crossref","unstructured":"F. Kawakami, H. Yanai, N. Teramoto, Y. Miyama, M. Yasuda, S. Minamiguchi, et al., Concordance between biopsy and resection diagnoses of uterine cervical adenocarcinoma according to the updated World Health Organization 2020 classification: a multi-institutional study elucidating real-world practice in Japan, Arch. Pathol. Lab Med. (2024). Volume 148, Issue 11, Pages 1218-1225","DOI":"10.5858\/arpa.2023-0360-OA"},{"key":"10.1016\/j.ygyno.2025.02.008_bb0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2024.02.001","article-title":"High concordance of molecular subtyping between pre-surgical biopsy and surgical resection specimen (matched-pair analysis) in patients with vulvar squamous cell carcinoma using p16- and p53-immunostaining","volume":"185","author":"H\u00f6hn","year":"2024","journal-title":"Gynecol. Oncol."}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825825000447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T21:17:10Z","timestamp":1744319830000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825825000447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":18,"alternative-id":["S0090825825000447"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.008","relation":{},"ISSN":["0090-8258"],"issn-type":[{"value":"0090-8258","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting lymph node metastases in three different vulvar squamous cell carcinoma subgroups","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ygyno.2025.02.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}